A Study of BGM0504 in Participants With Obesity

Who May Qualify: - ● Able and willing to provide a written willing to sign a consent form. - Male or female subjects, 18-65 years of age at the time of signing willing to sign a consent form. - At screening visit, 35.0 ﹤BMI﹤ 45.0 kg/m2; - Diet and exercise control for at least 3 months before screening visit, and be of stable weight (± 5%) self-reported change within the last 3 months. Who Should NOT Join This Trial: - ●History of chronic or acute pancreatitis. - History of severe drug allergy or specific allergic disease or severe allergies. - Family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2(MEN-2). - History of malignant tumors \[except carcinoma in situ with no recurrence within 5 years (except for malignant melanoma in situ), skin basal cell carcinoma and squamous cell carcinoma\]. - Suspected or confirmed history of alcohol or drug abuse; - Any chronic infections likely to interfere with study conduct or interpretation such as hepatitis B (HBV), hepatitis C (HCV), human weakened immune system virus (HIV) or treponema pallidum (TP). - Donation or loss of 400 mL or more of blood within 3 months prior to screening, or blood donation during screening or within 3 months after the end of the trial. - Pregnant or lactating woman. - Any disorder, unwillingness, or inability not covered by any of the other exclusion criteria, which in the Investigator's opinion, might jeopardize the participant's safety or compliance with the protocol. Always talk to your doctor about whether this trial is right for you.